Can-Fite BioPharma Files 6-K Report
Ticker: CANF · Form: 6-K · Filed: Apr 30, 2026 · CIK: 0001536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma Ltd. (CANF) |
| Form Type | 6-K |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-issuer, press-release
TL;DR
Can-Fite BioPharma filed a 6-K on 4/30/26 with a press release.
AI Summary
Can-Fite BioPharma Ltd. filed a Form 6-K on April 30, 2026, reporting as a foreign issuer. The filing includes a press release dated April 30, 2026, and other related documents. The company's mailing and business address is 26 Ben Gurion Street, Ramat Gan, Israel.
Why It Matters
This filing indicates ongoing reporting requirements for Can-Fite BioPharma as a foreign issuer, providing updates to investors and the market.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign issuer and does not contain significant new financial or operational information that would inherently increase risk.
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Filer
- 0001536196 (company) — CIK number for Can-Fite BioPharma Ltd.
- April 30, 2026 (date) — Period of Report and Press Release Date
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
When was this filing accepted by the SEC?
The filing was accepted on April 30, 2026.
What is the CIK number for Can-Fite BioPharma Ltd.?
The CIK number for Can-Fite BioPharma Ltd. is 0001536196.
What is the company's business address?
The company's business address is 26 Ben Gurion Street, Ramat Gan, L3 5257346.
What document is included as Exhibit EX-99.1?
Exhibit EX-99.1 is a press release dated April 30, 2026.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 30, 2026 regarding Can-Fite BioPharma Ltd. (CANF).